Medicem — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Medicem is an established, integrated biomedical company with a 30+ year history focused on hydrogel-based medical devices and drug delivery systems. It operates as a full-cycle entity from R&D to commercialization, with a marketed portfolio spanning multiple therapeutic areas including obstetrics/gynecology and ophthalmology. The company's core competency lies in its proprietary hydrogel chemistry platform, which it tailors to mimic living tissue for specific clinical applications. Leadership combines strong medical and business backgrounds, positioning the company to address unmet needs in global healthcare markets.

GynecologyOphthalmologyDermatologyWound CareSurgery

Technology Platform

Proprietary hydrogel chemistry platform for designing and manufacturing medical devices that mimic living tissue, enabling specific clinical applications in drug delivery and medical devices.

Opportunities

Large and growing global markets in advanced wound care, ophthalmology (IOLs), and gynecological procedures provide significant expansion potential.

The versatility of the hydrogel platform allows for continuous development of new products for unmet needs in existing and new therapeutic areas.

Geographic expansion of its already-commercialized portfolio into new regions offers a lower-risk growth pathway.

Risk Factors

Faces intense competition from large, global medical device corporations in its core markets.

Revenue may be susceptible to regulatory changes or reimbursement pressures in key geographic markets.

Long-term growth is dependent on sustained innovation from its R&D pipeline to avoid portfolio stagnation.

Competitive Landscape

Operates in competitive segments dominated by large medtech players (e.g., in wound care: Smith & Nephew, ConvaTec; in IOLs: Alcon, Johnson & Johnson). Its competitive advantage lies in its specialized, proprietary hydrogel expertise and ability to develop tailored solutions for specific clinical niches, potentially offering superior performance or cost-effectiveness versus broader competitors.

More companies in Drug Delivery & Formulation →More companies in Czech Republic →